Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA grants priority review to blood cancer treatment from Pharmacyclics
FDA grants priority review to blood cancer treatment from Pharmacyclics
FDA grants priority review to blood cancer treatment from Pharmacyclics
Submitted by
admin
on August 29, 2013 - 9:07am
Source:
Yahoo/AP
News Tags:
FDA
Pharmacyclics
Janssen
JNJ
ibrutinib
mantle cell lymphoma
chronic lymphocytic leukemia
Headline:
FDA grants priority review to blood cancer treatment from Pharmacyclics
Do Not Allow Advertisers to Use My Personal information
